Showing results (1461-1470 of 1,623) with videos related to
Sort By:
Pageof 163
Alimentary Pharmacology & Therapeutics|September 20, 2007
Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitisC Büning, H H-J Schmidt, T Molnar, et al.Gut|June 22, 2012
A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitisPaul J Rutgeerts, Richard N Fedorak, Daan W Hommes, et al.Kidney International Reports|April 30, 2025
Flow-Cytometric Quantification of Urine Kidney Epithelial Cells Specifically Reflects Tubular Damage in Acute Kidney DiseasesLeonie Wagner, Jacob Kujat, Valerie Langhans, et al.Scientific Reports|March 11, 2025
Relating the molecular phenotype of ulcerative colitis to the clinical courseKatelynn S Madill-Thomsen, Jeffery M Venner, Denise E Parsons, et al.Plos One|October 22, 2016
Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical StudyPirow Bekker, Daniel Dairaghi, Lisa Seitz, et al.Cytotherapy|February 6, 2018
Proceedings of the signature series event of the international society for cellular therapy: "Advancements in cellular therapies and regenerative medicine in digestive diseases," London, United Kingdom, May 3, 2017Rachele Ciccocioppo, Claudia C Dos Santos, Daniel C Baumgart, et al.Plos One|January 5, 2019
Correction: Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical StudyPirow Bekker, Daniel Dairaghi, Lisa Seitz, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|January 20, 2022
Immunoglobulin E Sensitization to Mammalian Oligosaccharide Galactose-α-1,3 (α-Gal) Is Associated With Noncalcified Plaque, Obstructive Coronary Artery Disease, and ST-Segment-Elevated Myocardial InfarctionStephen T Vernon, Katharine A Kott, Thomas Hansen, et al.Digestive Diseases and Sciences|March 17, 2025
Long-Term Effectiveness and Safety of Ustekinumab Dose Escalation in Patients with Moderate-to-Severe Ulcerative Colitis: A Multicenter Retrospective Cohort StudyLisa M A van Lierop, Larissa Albino, Ryan Rosentreter, et al.Nature Cardiovascular Research|December 23, 2024
Encompassing view of spatial and single-cell RNA sequencing renews the role of the microvasculature in human atherosclerosisTore Bleckwehl, Anne Babler, Merel Tebens, et al.Pageof 163